evista
eli lilly israel ltd, israel - raloxifene hydrochloride - film coated tablets - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.
auro-raloxifene
aurobindo pharma australia pty ltd - raloxifene hydrochloride -
raloxifene ly
eli lilly australia pty ltd - raloxifene hydrochloride -
act raloxifene tablet
teva canada limited - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists
apo-raloxifene tablet
apotex inc - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists
raloxifene 60mg tablets
sandoz ltd - raloxifene hydrochloride - tablet - 60mg
raloxifene 60mg tablets
mylan - raloxifene hydrochloride - tablet - 60mg
ostiral 60mg tablets
lupin healthcare (uk) ltd - raloxifene hydrochloride - oral tablet - 60mg
evista
eli lilly and company (nz) limited - raloxifene hydrochloride 60mg equivalent to 55.7 mg raloxifene free base - film coated tablet - 60 mg - active: raloxifene hydrochloride 60mg equivalent to 55.7 mg raloxifene free base excipient: carnauba wax crospovidone lactose lactose monohydrate magnesium stearate opacode blue s-1-10537g opadry white ys-1-18027-a polysorbate 80 povidone
genrx raloxifene raloxifene hydrochloride 60 mg tablet blister pack
apotex pty ltd - raloxifene hydrochloride -